A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease
Conditions
Degenerative Disc Disease
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Alabama Clinical Therapeutics, Birmingham, Alabama, United States
Contact: Principal Investigator (Brad 205-833-2228, MD)Source Healthcare, Santa Monica, California, United States
Contact: Principal Investigator (Timothy Davis, MD)Vantage Clinical Trials, St. Petersburg, Florida, United States
Contact: Principal Investigator (Robert Guirguis, MD)Vantage Clinical Trials, Tampa, Florida, United States
Contact: Principal Investigator (Jorge Leal, MD)Injury Care Family Care Research, Boise, Idaho, United States
Contact: Principal Investigator (Daniel Marsh, MD)Axis Spine Center, Post Falls, Idaho, United States
Contact: Principal Investigator (Jessica Jameson, MD)Indiana Spine Group, Carmel, Indiana, United States
Contact: Principal Investigator (Kevin Macadaeg, MD)The Orthopedic Center of St. Louis, St Louis, Missouri, United States
Contact: Principal Investigator (Matthew Gornet, MD)Wake Research, Wilmington, North Carolina, United States
Contact: Principal Investigator (Jeremy Hoff, MD)Carolinas Pain Institute/ Center For Clinical Research, Winston-Salem, North Carolina, United States
Contact: Principal Investigator (Christopher Gilmore, MD)Pacific Sports and Spine, Eugene, Oregon, United States
Contact: Principal Investigator (Gregory Moore, MD)Semmes Murphey Neurological Clinic, Memphis, Tennessee, United States
Contact: Principal Investigator (Michael LaBagnara, MD)Pain Specialists of America, Austin, Texas, United States
Contact: Principal Investigator (Genaro Gutierrez, MD)University of Utah, Salt Lake City, Utah, United States
Contact: Principal Investigator (Zachary McCormick, MD)
Study leads
Lisa Flood
Study Director
DiscGenics, Inc.